NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 187 filers reported holding NEVRO CORP in Q1 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $414,339 | +16.1% | 11,548 | +27.7% | 0.00% | – |
| Q4 2022 | $356,766 | -20.9% | 9,041 | -2.3% | 0.00% | -100.0% |
| Q3 2022 | $451,000 | +79.0% | 9,254 | +166.6% | 0.00% | – |
| Q1 2022 | $252,000 | -38.7% | 3,471 | +18.7% | 0.00% | – |
| Q1 2021 | $411,000 | +59.3% | 2,923 | +95.4% | 0.00% | – |
| Q4 2020 | $258,000 | -89.7% | 1,496 | -92.9% | 0.00% | -100.0% |
| Q2 2020 | $2,516,000 | +597.0% | 21,062 | +577.5% | 0.01% | +400.0% |
| Q4 2019 | $361,000 | +31.8% | 3,109 | -2.4% | 0.00% | 0.0% |
| Q3 2019 | $274,000 | -90.8% | 3,187 | -93.0% | 0.00% | -83.3% |
| Q2 2019 | $2,972,000 | +76.9% | 45,850 | +162.0% | 0.01% | +50.0% |
| Q1 2017 | $1,680,000 | +340.9% | 17,503 | +234.2% | 0.00% | +300.0% |
| Q4 2016 | $381,000 | – | 5,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |